GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (NAS:GILD) » Definitions » Dividends per Share
中文

Gilead Sciences (Gilead Sciences) Dividends per Share

: $3.00 (TTM As of Dec. 2023)
View and export this data going back to 1992. Start your Free Trial

Gilead Sciences's dividends per share for the three months ended in Dec. 2023 was $0.75. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.00. Its Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.44. As of today, Gilead Sciences's Dividend Yield % is 4.47%.

Good Sign:

Gilead Sciences Inc stock dividend yield is close to 10-year high.

During the past 12 months, Gilead Sciences's average Dividends Per Share Growth Rate was 2.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 3.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Gilead Sciences was 20.90% per year. The lowest was 3.30% per year. And the median was 8.50% per year.

For more information regarding to dividend, please check our Dividend Page.


Gilead Sciences Dividends per Share Historical Data

The historical data trend for Gilead Sciences's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.52 2.72 2.84 2.92 3.00

Gilead Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.75 0.75 0.75 0.75

Competitive Comparison

For the Drug Manufacturers - General subindustry, Gilead Sciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gilead Sciences Dividend Yield % Distribution

For the Drug Manufacturers industry and Healthcare sector, Gilead Sciences's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Gilead Sciences's Dividend Yield % falls into.



Gilead Sciences Dividends per Share Calculation

Dividends paid to per common share.


Gilead Sciences  (NAS:GILD) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Gilead Sciences's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0.75/ 1.72
=0.44

During the past 13 years, the highest Dividend Payout Ratio of Gilead Sciences was 0.78. The lowest was 0.11. And the median was 0.48.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Gilead Sciences Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.7702024-03-142024-03-152024-03-28Cash DividendquarterlyUSD:USD 1.000000
USD 0.7502023-12-142023-12-152023-12-28Cash DividendquarterlyUSD:USD 1.000000
USD 0.7502023-09-142023-09-152023-09-28Cash DividendquarterlyUSD:USD 1.000000
USD 0.7502023-06-142023-06-152023-06-29Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.


Gilead Sciences's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=3.02/67.41
=4.48 %

Current Share Price is $67.41.
Gilead Sciences's Dividends per Share for the trailing twelve months (TTM) ended in Today is $3.02.

During the past 13 years, the highest Dividend Yield of Gilead Sciences was 4.90%. The lowest was 0.36%. And the median was 3.50%.

Good Sign:

Gilead Sciences Inc stock dividend yield is close to 10-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gilead Sciences Dividends per Share Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Gilead Sciences (Gilead Sciences) Business Description

Address
333 Lakeside Drive, Foster, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Executives
Andrew D Dickinson officer: EVP, Chief Financial Officer 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Johanna Mercier officer: Chief Commercial Officer 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Merdad Parsey officer: Chief Medical Officer 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Sandra Patterson officer: SVP, Controllership 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Diane E. Wilfong officer: SVP, Controller & CAO 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Deborah H Telman officer: EVP, Corporate Affairs & GC 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Brett A Pletcher officer: EVP, Gen Counsel & Corp Sec 333 LAKESIDE DRIVE, FOSTER CITY X1 94404
Jeffrey Bluestone director C/O PROVENTION BIO, INC., P.O. BOX 666, OLDWICK NJ 08858
Anthony Welters director
Javier Rodriguez director 601 HAWAII ST., EL SEGUNDO CA 90245
John Francis Cogan director 2010 NORTH FIRST STREET, SUITE 310, SAN JOSE CA 95131
Gayle E Wilson director C/O GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Olsen Per Wold director C/O GILEAD SCIENCES, 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Sandra Horning director 333 LAKESIDE DRIVE, FOSTER CITY CA 94404
Richard James Whitley director UAB, CHB 303, 1600 7TH AVENUE SOUTH, BIRMINGHAM AL 35233-1711

Gilead Sciences (Gilead Sciences) Headlines